Novo Integrated Sciences
NVOS
$0.26
Share price
-5.75%
Change (1 day)
-85.21%
Change (1 year)
Categories
Revenue for Novo Integrated Sciences (NVOS)
Revenue in 2023 (TTM): $1.12 M
According to Novo Integrated Sciences's latest financial reports the company's current revenue (TTM) is $1.12 M. In 2022 the company made a revenue of $11.99 M an increase over the years 2021 revenue that were of $10.31 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Novo Integrated Sciences from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $1.12 M | -90.63% |
| 2022 | $11.99 M | 16.33% |
| 2021 | $10.31 M | 38.09% |
| 2020 | $7.46 M | -22.69% |
| 2019 | $9.65 M | 7.89% |
| 2018 | $8.95 M | 36.39% |
| 2017 | $6.56 M | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Select Medical Holdings SEM | $6.48 B | 577,383.79% | 🇺🇸 USA |
 HealthSouth
EHC | $4.57 B | 407,001.65% | 🇺🇸 USA |
 Novo Integrated Sciences NVOS | $1.12 M | 0.00% | 🇺🇸 USA |